Max Healthcare Institute Limited Share Price & Analysis
₹977Updated 5 Jun 2026, 03:30 pm IST
LTP
₹977
—
Open
₹977.1
High
₹978.95
Low
₹962.85
Close
₹966.2
52W High
₹1,314
52W Low
₹903
Volume
1317K
Lot Size
525
Sector
Healthcare
Market Cap
₹92K Cr
Face Value
₹10
Large CapNIFTY 100NIFTY 200NIFTY 50NIFTY 500
Price Chart
Fundamentals
P/E
62.2
Sector P/E
48.9
P/B
8.88
EPS
₹14.59
ROE
14.8%
ROCE
14.7%
D/E Ratio
0.32
Div Yield
0.16%
Book Value
₹110
+
Strengths
- ✓Low debt relative to equity (D/E 0.3x)
−
Concerns
- ✗High premium to book value (P/B 8.9x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
MAXHEALTH · as of Mar 2026
Promoters23.74%
FII54.74%▼2.19
DII17.59%▲2.04
Public3.94%▲0.17
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 23.75% | 23.75% | 23.74% | 23.74% | 23.74% | 23.74% |
| FII | 60.69% | 57.33% | 56.99% | 57.29% | 56.93% | 54.74% |
| DII | 11.55% | 14.96% | 15.36% | 15.14% | 15.55% | 17.59% |
| Public | 3.99% | 3.97% | 3.91% | 3.84% | 3.77% | 3.94% |
Corporate Events
To consider and approve the financial results for the quarter and financial year ended March 31, 2026 and dividend
Dividend20 May 2026
Dividend - Rs 1.50 Per Share
Dividend3 Jul 2025
Dividend - Rs 1.5 Per Share
Dividend22 Aug 2024
Dividend - Re 1 Per Share
Dividend7 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.1K Cr ▼3.1% | ₹2.1K Cr ▲5.3% | ₹2.0K Cr ▲6.2% | ₹1.9K Cr ▲2.2% | ₹1.9K Cr ▲9.4% | ₹1.7K Cr ▲10.6% | ₹1.5K Cr ▲8.4% | ₹1.4K Cr |
| Op. Profit | ₹538 Cr ▼6.4% | ₹575 Cr ▲9.9% | ₹523 Cr ▲2.1% | ₹512 Cr ▲2.6% | ₹499 Cr ▲10.6% | ₹451 Cr ▲16.5% | ₹387 Cr ▲1.3% | ₹382 Cr |
| OPM | 26.0% ▼3.7% | 27.0% ▲3.8% | 26.0% ▼3.7% | 27.0% ▲0.0% | 27.0% ▲3.8% | 26.0% ▲4.0% | 25.0% ▼7.4% | 27.0% |
| Net Profit | ₹301 Cr ▼38.7% | ₹491 Cr ▲59.4% | ₹308 Cr ▼3.4% | ₹319 Cr ▲33.5% | ₹239 Cr ▼15.2% | ₹282 Cr ▲19.5% | ₹236 Cr ▼6.3% | ₹252 Cr |
| EPS (₹) | 3.09 ▼38.8% | 5.05 ▲59.3% | 3.17 ▼3.4% | 3.28 ▲33.3% | 2.46 ▼15.2% | 2.9 ▲19.3% | 2.43 ▼6.2% | 2.59 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8.4K Cr ▲19.1% | ₹7.0K Cr ▲30.0% | ₹5.4K Cr ▲18.5% | ₹4.6K Cr ▲15.9% | ₹3.9K Cr ▲57.0% | ₹2.5K Cr ▲136.8% | ₹1.1K Cr ▼37.4% | ₹1.7K Cr ▼2.2% | ₹1.7K Cr ▲7.5% | ₹1.6K Cr |
| Expenses | ₹6.1K Cr ▲18.4% | ₹5.2K Cr ▲32.4% | ₹3.9K Cr ▲17.8% | ₹3.3K Cr ▲11.3% | ₹3.0K Cr ▲42.1% | ₹2.1K Cr ▲117.7% | ₹965 Cr ▼37.1% | ₹1.5K Cr ▼5.0% | ₹1.6K Cr ▲10.2% | ₹1.5K Cr |
| Op. Profit | ₹2.2K Cr ▲21.3% | ₹1.8K Cr ▲23.8% | ₹1.5K Cr ▲20.3% | ₹1.2K Cr ▲30.5% | ₹951 Cr ▲133.7% | ₹407 Cr ▲333.0% | ₹94 Cr ▼39.7% | ₹156 Cr ▲38.1% | ₹113 Cr ▼19.9% | ₹141 Cr |
| OPM | 27.0% ▲3.8% | 26.0% ▼7.1% | 28.0% ▲3.7% | 27.0% ▲12.5% | 24.0% ▲50.0% | 16.0% ▲77.8% | 9.0% ▲0.0% | 9.0% ▲28.6% | 7.0% ▼22.2% | 9.0% |
| Other Income | ₹114 Cr ▲39.0% | ₹82 Cr ▼53.7% | ₹177 Cr ▲27.3% | ₹139 Cr ▲26.4% | ₹110 Cr ▲190.2% | ₹-122 Cr ▼354.2% | ₹48 Cr ▼14.3% | ₹56 Cr ▼13.8% | ₹65 Cr ▲10.2% | ₹59 Cr |
| Interest | ₹235 Cr ▲42.4% | ₹165 Cr ▲175.0% | ₹60 Cr ▼28.6% | ₹84 Cr ▼16.8% | ₹101 Cr ▼43.6% | ₹179 Cr ▲115.7% | ₹83 Cr ▼17.8% | ₹101 Cr ▲2.0% | ₹99 Cr ▼1.0% | ₹100 Cr |
| Depreciation | ₹447 Cr ▲24.5% | ₹359 Cr ▲46.5% | ₹245 Cr ▲5.6% | ₹232 Cr ▲5.0% | ₹221 Cr ▲27.0% | ₹174 Cr ▲278.3% | ₹46 Cr ▼55.3% | ₹103 Cr ▲9.6% | ₹94 Cr ▼2.1% | ₹96 Cr |
| PBT | ₹1.7K Cr ▲19.2% | ₹1.4K Cr ▲3.0% | ₹1.4K Cr ▲28.3% | ₹1.1K Cr ▲44.0% | ₹739 Cr ▲1171.0% | ₹-69 Cr ▼630.8% | ₹13 Cr ▲62.5% | ₹8 Cr ▲153.3% | ₹-15 Cr ▼400.0% | ₹5 Cr |
| Tax % | 14.0% ▼41.7% | 24.0% ▲4.3% | 23.0% ▲675.0% | -4.0% ▼122.2% | 18.0% ▼73.1% | 67.0% ▲6800.0% | -1.0% ▼101.0% | 102.0% ▲56.9% | 65.0% ▲127.5% | -236.0% |
| Net Profit | ₹1.4K Cr ▲34.0% | ₹1.1K Cr ▲1.7% | ₹1.1K Cr ▼4.2% | ₹1.1K Cr ▲82.5% | ₹605 Cr ▲538.4% | ₹-138 Cr ▼333.9% | ₹59 Cr | ₹0 Cr ▲100.0% | ₹-25 Cr ▼256.3% | ₹16 Cr |
| EPS (₹) | 14.82 ▲33.9% | 11.07 ▲1.7% | 10.88 ▼4.3% | 11.37 ▲82.2% | 6.24 ▲539.4% | -1.42 ▼229.1% | 1.1 ▲1933.3% | -0.06 ▲87.2% | -0.47 ▼262.1% | 0.29 |
| Div Payout | 13.0% ▼7.1% | 14.0% ▲0.0% | 14.0% ▲55.6% | 9.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹972 Cr ▲0.0% | ₹972 Cr ▲0.0% | ₹972 Cr ▲0.1% | ₹971 Cr ▲0.1% | ₹970 Cr ▲0.4% | ₹966 Cr ▲79.9% | ₹537 Cr ▲0.0% | ₹537 Cr ▲0.0% | ₹537 Cr ▲0.0% | ₹537 Cr |
| Reserves | ₹9.1K Cr ▲8.0% | ₹8.4K Cr ▲13.1% | ₹7.4K Cr ▲15.5% | ₹6.4K Cr ▲21.2% | ₹5.3K Cr ▲13.7% | ₹4.7K Cr ▲131.8% | ₹2.0K Cr ▲373.2% | ₹426 Cr ▼32.1% | ₹627 Cr ▼4.3% | ₹655 Cr |
| Borrowings | ₹3.3K Cr ▲8.8% | ₹3.0K Cr ▲131.7% | ₹1.3K Cr ▲88.5% | ₹689 Cr ▼24.5% | ₹913 Cr ▼17.1% | ₹1.1K Cr ▲25.8% | ₹875 Cr ▼12.8% | ₹1.0K Cr ▲2.2% | ₹981 Cr ▲12.2% | ₹874 Cr |
| Other Liabilities | ₹3.0K Cr ▲5.7% | ₹2.8K Cr ▲21.9% | ₹2.3K Cr ▲14.5% | ₹2.0K Cr ▲0.5% | ₹2.0K Cr ▲10.5% | ₹1.8K Cr ▲230.2% | ₹546 Cr ▼60.7% | ₹1.4K Cr ▲20.1% | ₹1.2K Cr ▲7.1% | ₹1.1K Cr |
| Total Liabilities | ₹16.3K Cr ▲7.2% | ₹15.2K Cr ▲26.6% | ₹12.0K Cr ▲18.8% | ₹10.1K Cr ▲9.9% | ₹9.2K Cr ▲7.6% | ₹8.5K Cr ▲115.0% | ₹4.0K Cr ▲18.5% | ₹3.4K Cr ▲1.6% | ₹3.3K Cr ▲5.0% | ₹3.1K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹11.8K Cr ▲2.8% | ₹11.5K Cr ▲30.9% | ₹8.8K Cr ▲24.8% | ₹7.0K Cr ▲0.3% | ₹7.0K Cr ▲7.4% | ₹6.5K Cr ▲668.0% | ₹851 Cr ▼61.2% | ₹2.2K Cr ▼1.6% | ₹2.2K Cr ▼0.8% | ₹2.2K Cr |
| CWIP | ₹1.2K Cr ▲36.1% | ₹901 Cr ▲62.9% | ₹553 Cr ▲119.4% | ₹252 Cr ▲66.9% | ₹151 Cr ▲459.3% | ₹27 Cr ▼3.6% | ₹28 Cr ▼67.8% | ₹87 Cr ▲128.9% | ₹38 Cr ▼17.4% | ₹46 Cr |
| Investments | ₹5 Cr ▲66.7% | ₹3 Cr ▲50.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼100.0% | ₹2.2K Cr ▲218100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹3.2K Cr ▲15.9% | ₹2.8K Cr ▲4.5% | ₹2.7K Cr ▼5.3% | ₹2.8K Cr ▲39.1% | ₹2.0K Cr ▲2.0% | ₹2.0K Cr ▲116.9% | ₹913 Cr ▼15.1% | ₹1.1K Cr ▲3.8% | ₹1.0K Cr ▲21.0% | ₹856 Cr |
| Total Assets | ₹16.3K Cr ▲7.2% | ₹15.2K Cr ▲26.6% | ₹12.0K Cr ▲18.8% | ₹10.1K Cr ▲9.9% | ₹9.2K Cr ▲7.6% | ₹8.5K Cr ▲115.0% | ₹4.0K Cr ▲18.5% | ₹3.4K Cr ▲1.6% | ₹3.3K Cr ▲5.0% | ₹3.1K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹1.6K Cr ▲11.9% | ₹1.5K Cr ▲30.0% | ₹1.1K Cr ▼12.6% | ₹1.3K Cr ▲73.3% | ₹741 Cr ▲528.0% | ₹118 Cr ▲53.2% | ₹77 Cr ▼13.5% | ₹89 Cr ▼46.4% | ₹166 Cr ▲6.4% | ₹156 Cr |
| Investing CF | ₹-1.7K Cr ▼4.6% | ₹-1.6K Cr ▼28.8% | ₹-1.3K Cr ▼1128.4% | ₹-102 Cr ▲86.6% | ₹-764 Cr ▼470.9% | ₹206 Cr ▲107.8% | ₹-2.6K Cr ▼15435.3% | ₹-17 Cr ▲86.3% | ₹-124 Cr ▼19.2% | ₹-104 Cr |
| Financing CF | ₹59 Cr ▲136.0% | ₹-164 Cr ▲37.9% | ₹-264 Cr ▲8.7% | ₹-289 Cr ▲1.7% | ₹-294 Cr ▼253.9% | ₹191 Cr ▼91.9% | ₹2.4K Cr ▲3279.7% | ₹-74 Cr ▼54.2% | ₹-48 Cr ▲0.0% | ₹-48 Cr |
| Net Cash Flow | ₹4 Cr ▲101.3% | ₹-319 Cr ▲19.2% | ₹-395 Cr ▼144.2% | ₹893 Cr ▲381.7% | ₹-317 Cr ▼161.4% | ₹516 Cr ▲345.7% | ₹-210 Cr ▼10400.0% | ₹-2 Cr ▲66.7% | ₹-6 Cr ▼250.0% | ₹4 Cr |
| Free Cash Flow | ₹165 Cr ▼67.0% | ₹500 Cr ▲46.2% | ₹342 Cr ▼64.1% | ₹952 Cr ▲395.8% | ₹192 Cr ▲19100.0% | ₹1 Cr ▲107.7% | ₹-13 Cr ▲51.9% | ₹-27 Cr ▼127.0% | ₹100 Cr ▲143.9% | ₹41 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 42d ▲16.7% | 36d ▲16.1% | 31d ▲14.8% | 27d ▼25.0% | 36d ▼32.1% | 53d ▲60.6% | 33d ▼57.7% | 78d ▲32.2% | 59d ▲11.3% | 53d |
| Inventory Days | 23d ▼11.5% | 26d ▲0.0% | 26d ▼13.3% | 30d ▲25.0% | 24d ▼29.4% | 34d ▼20.9% | 43d ▲65.4% | 26d ▲8.3% | 24d ▲20.0% | 20d |
| Days Payable | 175d ▼12.5% | 200d ▼3.4% | 207d ▼3.7% | 215d ▲23.6% | 174d ▼36.5% | 274d ▼4.2% | 286d ▼2.1% | 292d ▲28.6% | 227d ▲23.4% | 184d |
| Cash Conv. Cycle | -110d ▲20.3% | -138d ▲7.4% | -149d ▲5.7% | -158d ▼38.6% | -114d ▲39.0% | -187d ▲11.0% | -210d ▼11.7% | -188d ▼30.6% | -144d ▼29.7% | -111d |
| Working Capital Days | -41d ▲12.8% | -47d ▼9.3% | -43d ▲6.5% | -46d ▼91.7% | -24d ▲45.5% | -44d ▲67.9% | -137d ▲9.9% | -152d ▼533.3% | -24d ▼100.0% | -12d |
| ROCE | 15.0% ▲0.0% | 15.0% ▼6.3% | 16.0% ▲6.7% | 15.0% ▲25.0% | 12.0% ▲71.4% | 7.0% ▲75.0% | 4.0% ▼33.3% | 6.0% ▲50.0% | 4.0% | — |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Max Healthcare Institute Limited
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Max Healthcare Institute Limited share price today?▾
Max Healthcare Institute Limited (MAXHEALTH) is currently trading at ₹977 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Max Healthcare Institute Limited available in F&O (Futures & Options)?▾
Yes, Max Healthcare Institute Limited (MAXHEALTH) is part of the NSE F&O segment with a lot size of 525 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Max Healthcare Institute Limited 52-week high and low?▾
Max Healthcare Institute Limited's 52-week high is ₹1,314 and the 52-week low is ₹903. The current price of ₹977 is 25.6% below the 52W high.
What is Max Healthcare Institute Limited P/E ratio?▾
Max Healthcare Institute Limited's current P/E ratio is 62.2. This indicates the market is paying ₹62.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Max Healthcare Institute Limited options?▾
Max Healthcare Institute Limited options are traded on NSE with monthly expiry contracts (lot size: 525 shares). To trade MAXHEALTH options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.